Experimental AI Program Can Accurately Spot Lung Cancer
An NYU Langone artificial intelligence project identifies lung cancer as accurately as pathologists—and spots mutations in minutes.
Experimental Asthma Drug Doesn’t Weaken Flu Defenses
NYU Langone researchers discover a way to suppress the most common form of asthma without compromising the body’s defenses against flu viruses.
Experimental Cancer Drug Could Extend Women’s Fertility
NYU Langone researchers find that an experimental immunosuppressant drug could extend women’s fertility.
Experimental Compound Counters Diabetic Complications
NYU Langone researchers find experimental compound counters the consequences of diabetes, including cell death, inflammation, and organ damage.
Experimental COVID-19 Drug Shows Promise in Initial Research
Researchers from NYU Grossman School of Medicine and Pfizer find an experimental protease inhibitor can block the reproduction of SARS-CoV-2.
Experimental Drug Stops COVID-19 Viral Entry into Lung Cells
NYU Langone researchers have found that an experimental compound could prevent the virus that causes COVID-19 from entering human lung cells.
Experimental Pancreatic Cancer Treatment Shows Promise
Oncologist Dr. Paul E. Oberstein at NYU Langone’s Perlmutter Cancer Center, discusses an experimental treatment for metastatic pancreatic cancer.
Experimental Prostate Cancer Drug Is First of Its Kind
NYU Langone researchers find that a new type of molecule blocks the action of genes that drive the growth of therapy-resistant prostate cancer.
Experimental Therapy Speeds Up Wound Healing in Diabetes
NYU Langone study shows that injecting wounded skin with stem cells can speed up healing by more than 50 percent in mice with diabetes.
Experimental Treatment Improves Survival for Breast Cancer
Five years after receiving an experimental treatment for breast cancer at NYU Langone’s Perlmutter Cancer Center, a woman is cancer-free.